Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 293

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis

Open access
Kheirollahi, Vahid, Wasnick, Roxana M., Biasin, Valentina, Vazquez-Armendariz, Ana Ivonne, Chu, Xuran, Moiseenko, Alena, Weiss, Astrid, Wilhelm, Jochen, Zhang, Jin-San, Kwapiszewska, Grazyna, Herold, Susanne, Schermuly, Ralph T., Mari, Bernard, Li, Xiaokun, Seeger, Werner, Günther, Andreas, Bellusci, Saverio, El Agha, Elie·2019·Nature Communications

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which the intricate alveolar network of the lung is progressively replaced by fibrotic scars. Myofibroblasts are the effector cells that excessively deposit extracellular matrix proteins thus compromising lung structure and function. Emerging literature suggests a correlation between fibrosis and metabolic alterations in IPF. In this study, we show that the first-line antidiabetic drug metformin exerts potent antifibrotic effects in the lung by modulating metabolic pathways, inhibiting TGFβ1 action, suppressing collagen formation, activating PPARγ signaling and inducing lipogenic differentiation in lung fibroblasts derived from IPF patients. Using genetic lineage tracing in a murine model of lung fibrosis, we show that metformin alters the fate of myofibroblasts and accelerates fibrosis resolution by inducing myofibroblast-to-lipofibroblast transdifferentiation. Detailed pathway analysis revealed a two-arm mechanism by which metformin accelerates fibrosis resolution. Our data report an antifibrotic role for metformin in the lung, thus warranting further therapeutic evaluation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-10839-0

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 293

Metadata

Authors
Kheirollahi, V., Wasnick, R. M., Biasin, V., Vazquez-Armendariz, A. I., Chu, X., Moiseenko, A., Weiss, A., Wilhelm, J., Zhang, J.-S., Kwapiszewska, G., Herold, S., Schermuly, R. T., Mari, B., Li, X., Seeger, W., Günther, A., Bellusci, S., & El Agha, E.
Venue
Nature Communications
Published
2019-07-05
Volume
10
Issue
1
Pages
2987-2987
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2955212273
Cited by
293
References
56
FWCI
22.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis. https://app.cochat.ai/papers/10.1038/s41467-019-10839-0
The paper
Kheirollahi, V., Wasnick, R. M., Biasin, V., Vazquez-Armendariz, A. I., Chu, X., Moiseenko, A., Weiss, A., Wilhelm, J., Zhang, J.-S., Kwapiszewska, G., Herold, S., Schermuly, R. T., Mari, B., Li, X., Seeger, W., Günther, A., Bellusci, S., & El Agha, E. (2019). Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis. Nature Communications. https://doi.org/10.1038/s41467-019-10839-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.